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Hypotrichosis with juvenile macular dystrophy is a rare
autosomal recessive disorder characterized by abnormal
growth of scalp hair during infancy, and by the later oc-
currence of macular degeneration leading to blindness
during the ¢rst to third decade of life. Hypotrichosis
with juvenile macular dystrophy was recently shown to
result from mutations in CDH3 encoding P-cadherin.
In this study, we assessed 27 individuals, including nine
patients, belonging to ¢ve families in an attempt to
characterize further the CDH3 mutation spectrum and
delineate possible phenotype^genotype correlations.
Deleterious biallelic mutations, predicted to lead to the
translation of a dysfunctional protein, were found in all
a¡ected individuals. Four of these mutations are novel.
A¡ected individuals of two large separate apparently
unrelated families of Arab Israeli origin were found
to carry the same homozygous mis-sense mutation
(R503H) in exon 11 of the CDH3 gene. This mutation,
which alters a Ca2þ -binding site in the fourth extracel-
lular domain of P-cadherin, was previously described
in a third unrelated Arab Israeli family. Using haplotype
analysis for a series of polymorphic markers encom-
passing the CDH3 gene, we obtained evidence suggest-
ing a founder e¡ect for R503H in the Arab Israeli
population. We also compared the dermatologic and
ophthalmologic features of 22 hypotrichosis with juve-
nile macular dystrophy patients with known recessive
mutations in CDH3.Whereas hair paucity and macular
degeneration were found in all patients, we noticed sig-
ni¢cant interfamilial and intrafamilial di¡erences in
hair morphology, associated skin ¢ndings as well as se-
verity and age of onset of visual disability. Altogether,
our results obtained in a series of families of various
ethnic origins ¢rmly establish mutations in CDH3 as
the proximal cause of hypotrichosis with juvenile ma-
cular dystrophy and demonstrate genetic homogeneity
as well as phenotypic heterogeneity in this disorder.
Key words: atrichia/hair/hypotrichosis/lentigo/macular degen-
eration/pigmentation/retinal dystrophy. J Invest Dermatol
121:1217 ^1220, 2003
H
ypotrichosis with juvenile macular dystrophy
(HJMD; MIM601553) is a rare autosomal recessive
disorder characterized by early hair loss followed
by progressive degeneration of the central retina,
culminating in blindness. The syndrome was re-
cently shown to result from mutations in CDH3 on 16q21 (Spre-
cher et al, 2001; Indelman et al, 2002). CDH3 encodes P-cadherin
(Shimoyama et al, 1989), a classical cadherin, which is strongly ex-
pressed in both the hair follicle and the retinal pigment epithe-
lium (Muller-Rover et al, 1999; Xu et al, 2002). Indirect evidence
suggests that P-cadherin de¢ciency may lead to abnormal hair
development by interfering with b-catenin function (Indelman
et al, 2002). Also, retinal pigment epithelial cell development has
been shown to depend on a number of components of the wnt/b-
catenin signaling system (Olschwang et al, 1993; Liou et al, 2002).
Alternatively, as classical cadherins are responsible for ensuring
cell^cell adhesion at the adherens junction, aberrant hair and ret-
inal di¡erentiation may be the consequence of weak or absent
cell^cell contact within the upper hair matrix zone or between
retinal pigment epithelial cells (Indelman et al, 2002).
In this study, we assessed a series of a¡ected individuals with
the clinical features of HJMD (Table I). We obtained informed
and written consent from each participant according to a proto-
col reviewed and approved by the institutional board (Helsinki
Committee) and by the Committee for Genetic Studies of Israeli
Ministry of Health. Family 1 is French origin and has been de-
scribed elsewhere (Raison-Peyron et al, 2000). Family 2 originates
from the Turkish mainland and family 3 lives in Turkish Cyprus.
Families 4 and 5 are of Arab Israeli extraction, unrelated and deny
any relationship with another Arab Israeli HJMD family pre-
viously described (Indelman et al, 2002). All a¡ected individuals
were found to display abnormally sparse hair at birth that never
grew thereafter.Whereas scalp hair of most individuals was short
and ¢rmly rooted in the scalp, the hair of individuals 5^7 and
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5^12 (Fig 1c) was curly and could easily be plucked out. The lat-
ter two patients displayed centrofacial lentiginosis (Fig 1a). All
individuals except from the three a¡ected children of family 5
displayed decreased visual acuity. Microscopic examination of
hair revealed a variety of anomalies (Table I). In all a¡ected fa-
milies, eye fundus examination disclosed degenerative changes
of the macula and electrophysiologic studies con¢rmed abnormal
function of the posterior pole.
We screened the entire coding sequence of CDH3 as pre-
viously described (Indelman et al, 2002) and identi¢ed biallelic
mutations in all a¡ected individuals of families 1 to 5 (Table I).
Interestingly, the proband of family 1was found to carry two het-
erozygous pathogenic sequence alterations, and thus represents
the ¢rst case of compound heterozygosity for mutations in
CDH3 (Fig 1b). Patients in families 1 to 3 were found to carry
mutations predicted to introduce premature termination codons
and to result either in mRNA decay or in the translation of a
truncated cadherin molecule (Fig 1b). All a¡ected members of
families 4 and 5 were homozygous for a G-A transition at
CDH3 cDNA position 1508.This mutation results in the substitu-
tion of a histidine residue for an arginine residue at position 503
of the amino acid sequence (R503H).We con¢rmed segregation
of the mutation in both families using a polymerase chain reac-
tion^restriction fragment length polymorphism assay previously
described (Indelman et al, 2002) (Fig 1c). R503H has previously
been reported in another apparently unrelated kindred of Arab
Israeli origin (Indelman et al, 2002) (family 6,Table I), suggesting
the possibility that the mutation originated from a common
founder. To test this hypothesis, we genotyped the members of
all three families for seven polymorphic markers spanning the
CDH3 locus over 19 cM as previously described (Sprecher et al,
2001). Haplotype analysis revealed that all a¡ected individuals
shared a homozygous 0.5 Mb chromosomal segment between
marker D16S3025 and marker D16S3067 (Fig 1d). These data sup-
port a founder e¡ect for R503H in the Arab Israeli population.
We compared dermatologic features (e.g., hair morphology
and associated skin ¢ndings) as well as ophthalmologic features
(e.g., age of onset of visual disability and visual acuity) with the
results of the mutation analysis (Table I). No systematic correla-
tion could be established between phenotypic characteristics and
the type (mis-sense vs non-sense/frameshift) or location of the
CDH3 mutations among 22 HJMD patients. Phenotypic hetero-
geneity and lack of phenotype^genotype correlation were not
only observed across various ethnic backgrounds or between fa-
milies carrying the same mutation on an identical genetic back-
ground but also within single families. Patients carrying the same
mutation (R503H) on the same haplotype background (families
4^6) exhibited divergent cutaneous features: two ¢rst-degree af-
fected cousins demonstrated centrofacial lentiginosis and telogen
e¥uvium (individuals 5^7 and 5^12), whereas other patients, such
as the brother of patient 5^7, did not. Patients carrying other
mutations in CDH3 demonstrated hair morphologic abnormal-
ities or had normal hair microscopic examination (Table I).Wide
variations in age of onset and degree of visual disability were ob-
served among patients, even when carrying identical mutations.
Finally, no correlation could be established between the type of
hair anomaly and the degree of macular damage.
Since the initial identi¢cation of a deleterious CDH3mutation
in several consanguineous families, a total of six mutations in 10
separate families of various ethnic origins have been reported to
cause HJMD (Table I). Two of these mutations, 981delG and
R503H, were observed repeatedly, re£ecting founder e¡ects in
the Druze and Arab Israeli populations, respectively. All six mu-
tations are expected to impair markedly the function of P-cad-
herin. Five of these mutations (981delG, L168X, 2112delG,
462delT, 829delG) are predicted to result in the synthesis of a
truncated form of P-cadherin or in the absence of P-cadherin.
The sixth mutation, R503H, alters a highly conserved motif lo-
cated within the fourth extracellular domain of P-cadherin (In-
delman et al, 2002). This motif plays an important part in Ca2þ
binding and determination of the ¢nal P-cadherin conformation
(Troyanovsky, 1999). Mutations a¡ecting the DRE motif have
also been recently described in CDH23, a gene mutated in Usher
syndrome type 1D and coding for a protocadherin involved in
stereocilia organization in hair cells (Astuto et al, 2002).
In addition, based on the examination of the largest series of
HJMD-a¡ected individuals described to date, we observed
substantial interfamilial phenotypic variation (Table I). Family 5
demonstrated an intriguing case of intrafamilial phenotypic
heterogeneity. Two of three a¡ected individuals in this family
displayed centrofacial lentiginosis. We could not ¢nd in the
literature any report of an association between congenital hypo-
trichosis, telogen e¥uvium and centrofacial lentiginosis as
observed in family 5. Although it is unlikely that centrofacial len-
tiginosis represents a direct manifestation of a CDH3mutation in
family 5, it is striking to note that the two children with centro-
facial lentiginosis also presented with curly hair and massive telo-
gen e¥uvium, which were not observed in other HJMD patients,
including another a¡ected sibling. Taken together, these observa-
tions may suggest the e¡ect of a recessively inherited and non-
linked modi¢er trait, modulating the phenotypic expression of
HJMD in family 5. The association of hair abnormalities with
aberrant pigmentation is particularly interesting in view of
mounting evidence suggesting interdependence between hair
Table I. Mutation spectrum and phenotype diversity in HJMD
Family Origin
Scalp
hypotrichosis Hair changes
Decreased
visual
acuitya
Macular
pigment
degeneration
Abnormal
electrophysiologic
studiesd
Associated
clinical
¢ndings Mutation Exon Reference
1 French þ None þ (35) þ þ Atopic dermatitis L168X/2112delG 5/14 This study
2f Turkish þ NAe þ (2) þ þ ^ 462delT/462delT 5 This study
3f Turkish þ NA þ (5) þ þ Keratosis pilaris 829delG/829delG 7 This study
4f Arab Israeli þ Pili torti þ (1) þ þ ^ R503H/ R503H 11 This study
5f Arab Israeli þ Telogen e¥uviumb c þ þ Centro- facial
lentiginesb,g
R503H/ R503H 11 This study
6f Arab Israeli þ Pili torti þ (4) þ þ ^ R503H/ R503H 11 Indelman
et al (2002)
7f Druze þ Pseudomonilethrix þ (15) þ þ ^ 981delG/981delG 8 Sprecher
et al (2001)
aEarliest age of onset in each family is given in parentheses.
bObserved in two of three a¡ected children.
cEldest child was 14 y of age at the time of examination.
dIncluded £ash-electroretinogram, £ash-visual evoked potentials and electrooculogram.
eNA, not available (Permission to obtain hair samples or skin biopsy was denied).
fConsanguineous family.
gPartial syndactyly in individual 7^12.
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development, hair cycling, and melanocyte lineage ontogenesis
(Ideta et al, 2002; Nishimura et al, 2002).
In summary, these results obtained in a series of families of var-
ious ethnic origins ¢rmly establish mutations in CDH3 as the
proximal cause of HJMD and demonstrate genetic homogeneity
as well as phenotypic heterogeneity in this disorder. The identi-
¢cation of asymptomatic macular damage in family 5 patients
suggests that ophthalmologic examination should become an
integral part of the diagnostic work-up of patients presenting
with recessive hypotrichosis.
Figure1. A feature analysis of HJMD family. (a) Curly and short hair as well as numerous lentigines on both sides of the nose and on the cheeks are
present in a¡ected individual 5^7 of family 5. (b) Mutation analysis. Analysis of the CDH3 coding sequence revealed an heterozygous non-sense mutation
in exon 5 (L168X) and an heterozygous deletion in exon 14 (2112delG) in family 1 patient; an homozygous 462delTmutation in exon 5 in family 2 patient;
an homozygous 829delG mutation in exon 7 in family 3 patient (left panels).The right panels give the corresponding wild-type sequences. (c) Segregation of
R503H in family 4 and family 5 demonstrated by polymerase chain reaction^restriction fragment length polymorphism. Exon 11 was polymerase chain
reaction-ampli¢ed from each member of the two families. A 223 bp long polymerase chain reaction fragment was digested with BsiEI. R503H abolishes a
recognition site for BsiEI: thus a¡ected individuals display a 223 bp fragment, healthy homozygous individuals display a 146 bp fragment and carriers of the
mutation display both fragments. The lower band of 77 bp is not shown. (d) Haplotype analysis in three HJMD families. Family 6 has previously been
characterized (Indelman et al, 2002). All family members were genotyped using seven microsatellite markers encompassing the CDH3 gene.
MUTATION SPECTRUM IN HJMD 1219VOL. 121, NO. 5 NOVEMBER 2003
We deeply acknowledge the HJMD families for having participated in this study.We
would like to thank Mr D.Taylor for referring family 2 and Mr D. Sandhu for refer-
ring family 3.We are grateful toV. Friedman PhD for DNA sequencing services.This
study was supported in part by theTechnion Research Fund and by a grant from Ram-
bam Medical Center R&D division.
REFERENCES
Astuto LM, Bork JM,Weston MD: CDH23 mutation and phenotype heterogeneity:
A pro¢le of 107 diverse families with Usher syndrome and nonsyndromic
deafness. AmJ Hum Genet 71:262^275, 2002
Ideta R, SomaT,Tsunenaga M, Ifuku O: Cultured human dermal papilla cells secrete
a chemotactic factor for melanocytes. J Dermatol Sci 28:48^59, 2002
Indelman M, Bergman R, Lurie R, et al: A mis-sense mutation in CDH3, encoding
P-cadherin, causes hypotrichosis with juvenile macular dystrophy. J Invest Der-
matol 119:1210^1213, 2002
Liou GI, Matragoon S, Samuel S, et al: DMMAP kinase and beta-catenin signaling
in HGF induced RPE migration. MolVis 8:483^493, 2002
Muller-Rover S, Tokura Y,Welker P, Furukawa F,Wakita H, Takigawa M, Paus R:
E- and P-cadherin expression during murine hair follicle morphogenesis and
cycling. Exp Dermatol 8:237^246, 1999
Nishimura EK, Jordan SA, Oshima H, et al: Dominant role of the niche in melano-
cyte stem-cell fate determination. Nature 416:854^860, 2002
Olschwang S,Tiret A, Laurent-Puig P, et al: Restriction of ocular fundus lesions to a
speci¢c subgroup of APC mutations in adenomatous polyposis coli patients.
Cell 75:959^968, 1993
Raison-Peyron N, Duval PA, Barneon G, Durand L, Arnaud B, Meynadier J, Hamel
C: A syndrome combining severe hypotrichosis and macular dystrophy: Ab-
sence of mutations in TIMP genes. Br J Dermatol 143:902^904, 2000
Shimoyama Y, Yoshida T, Terada M, Shimosato Y, Abe O, Hirohashi S: Molecular
cloning of a human Ca2þ -dependent cell^cell adhesion molecule homolo-
gous to mouse placental cadherin: Its low expression in human placental tis-
sues. J Cell Biol 109:1787^1794, 1989
Sprecher E, Bergman R, Richard G, et al: Hypotrichosis with juvenile macular dys-
trophy is caused by a mutation in CDH3 encoding P-cadherin. Nature Genet
29:134^136, 2001
Troyanovsky SM: Mechanisms of cell^cell adhesion complex assembly. Curr Opin
Cell Biol 11:561^566, 1999
Xu L, Overbeek PA, Reneker LW: Systematic analysis of E-, N- and P-cadherin ex-
pression in mouse eye development. Exp Eye Res 74:753^760, 2002
CD34 in Human Hair Follicle
To the Editor:
CD34, also known as human hematopoietic progenitor cell anti-
gen, is a heavily glycosylated transmembrane protein expressed
on developmentally early lymphohematopoietic stem and pro-
genitor cells, and on a signi¢cant number of acute leukemias
(Krause et al, 1996). In human skin CD34 has been described in
vascular endothelial cells, in a subset of dendritic/spindle-shaped
cells (Nickolo¡, 1991), and in some cutaneous tumors (Cohen et al,
1997).
In a previously published study we could demonstrate the ex-
pression of CD34 in cells from the outer root sheath of hair fol-
licles (Poblet et al, 1994). In that study, sections from normal
human skin of formalin-¢xed, para⁄n-embedded biopsies were
immunostained with a monoclonal antiCD34 antibody (clone
QBEND/10). A clear membranous staining of outer root sheath
cells could be observed. This was the ¢rst report to demonstrate
the CD34 expression in a certain type of keratinocytes. We
showed that the CD34 staining was very speci¢c for epithelial
cells of the external root sheath, and that the staining was limited
to cells located below the attachment of the arrector pili muscle
and above the matrix cells. Because CD34 is a progenitor cell
antigen we suggested a possible relation of these cells with stem
cells of hair follicles.
We read with interest the excellent article byTrempus et al that
has recently appeared in this Journal (Trempus et al, 2003). These
authors demonstrate CD34 immunohistochemical staining of
murine hair follicle bulge keratinocytes. In addition they con-
¢rmed the presence of CD34 mRNA in that cells. In general,
the immunohistochemical staining pattern of murine keratinocytes
concords with the staining pattern that we described in
human hair follicle keratinocytes, although the bulge region in
human hair follicles can not be as readily identi¢ed as it is in mice
hair follicles.
Enrique Poblet MD and Francisco JimeŁ nez MDwDepartment of Pathology, Hospital General Universitario de
Albacete, Spain; wDermatology and Laser Center Cl|¤ nica San Roque,
Las Palmas Gran Canaria, Canary Islands, Spain.
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Response
To the Editor:
We are writing in response to the Letter to the Editor
submitted by Poblet and Jiminez entitled ‘‘CD34 in the Human
Hair Follicle.’’ In this letter, they point out that we neglected
to refer to their 1994 paper ‘‘QBEND/10 (Anti-CD34 Antibody)
in External Root Sheath Cells and Follicular Tumors’’ (Poblet
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